Inside the hunt for a Covid-19 vaccine: how BioNTech made the breakthrough

The couple behind the German company are pioneers in a technology that could transform medicine

16 November 2020 - 20:14 By Joe Miller

The call came on the evening of November 8, as doctors Ugur Sahin and Ozlem Tureci were catching up with paperwork at their modest home near the German city of Mainz. It confirmed that their at-times-controversial lives’ work had produced a breakthrough that could offer humanity a route out of the Covid-19 pandemic.

A vaccine candidate developed by the company they cofounded 12 years ago, BioNTech, was more than 90% effective in preventing the disease, a far higher level than the widely used jabs for flu, shingles or rabies. It proved for the first time that the deadly virus could be vanquished by science...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.